METABOLIC EFFECTS OF THYROID HORMONE
METABOLIC EFFECTS OF THYROID HORMONE
批准号:
2391302
负责人:
HERBERT H SAMUELS
金额:
$62.26万
依托单位国家:
美国
项目类别:
财政年份:
1976
资助国家:
美国
项目状态:
已结题
起止时间:
1976-03-01 至 1999-03-31
关键词:
DNA binding protein Escherichia coli affinity chromatography affinity labeling cell growth regulation circular dichroism conformation fibroblasts gel mobility shift assay gene expression genetic manipulation genetic regulatory element genetic transcription growth factor receptors hormone metabolism hormone receptor hormone regulation /control mechanism human genetic material tag human tissue ligands molecular cloning nuclear magnetic resonance spectroscopy protein purification retinoate site directed mutagenesis somatotropin thyroid hormones tissue /cell culture transcription factor transfection
中文摘要
甲状腺激素受体(c-erbAs)和视黄酸受体(RARs)
是密切相关的核受体蛋白亚组的成员。
c-erbA和RAR可以各自激活某些应答元件,并且两者都可以激活。
受体包含嵌入配体中的高度保守的结构域
结合区含有一系列“亮氨酸拉链样”疏水
七肽基序。 功能研究表明,七肽重复结构域
介导c-erbA和RAR的同源和异源二聚体相互作用,或
与其他因素的相互作用。 鸡c-erbA-α和人RAR-α
在E. coli中,并纯化至接近均一。 这些
受体以适当的亲和力结合配体,并形成同源和
允许二聚化的应答元件上的异源二聚体。
配体促进二聚体形成,表明配体介导
通过这种机制激活转录。 本申请是
关于界定所涉职能领域的综合建议
c-erbA、RAR及相关因子在转录激活中的作用。 为
这些研究我们构建了一个多功能的细菌/真核生物
表达载体(pEXPRESS),其允许定点诱变,
可用于真核细胞中受体的功能分析,
在E.杆菌 凝胶位移研究,使用
纯化的野生型和突变型受体蛋白以及多种天然的
并提出了综合反应元素来阐明“规则”
控制这些受体如何识别功能性反应元件。
这些研究还将确定对人类和哺乳动物的重要受体结构域。
异源二聚体形成,用于受体之间的协同相互作用
和其他因素,以及占主导地位的负面活动。 可能
c-erbA亚型(β 1和β 1)识别元件的差异
也将与研究一起进行沿着,以了解
以及c-erbA-alpha 2如何作为一种显性基因发挥作用
负调节器 这些研究将通过分析
甲状腺激素受体突变体
抵抗综合征 哺乳动物细胞的功能研究将是
扩展到体外转录,目的是定义蛋白质
以及这些受体对转录增强的DNA需求。
最后,对mg量的纯化E.杆菌表达
野生型c-erbA及其DNA结合结构域将允许环状
二向色性、荧光和紫外-可见光谱(两者
蛋白质)和核磁共振研究(DNA结合域),
提供结构信息,以阐明功能和物理
这些蛋白质在分子水平上的特性。
英文摘要
Thyroid hormone receptors (c-erbAs) and retinoic acid receptors (RARs)
are members of a subgroup of closely related nuclear receptor proteins.
c-erbAs and RAR can each activate certain response elements and both
receptors contain a highly conserved domain embedded within the ligand
binding region containing a series of "leucine-zipper-like" hydrophobic
heptad motifs. Functional studies suggest that the heptad repeat domain
mediates homo- and heterodimeric interactions of c-erbA and RAR or
interactions with other factors. Chick c-erbA-alpha and human RAR-alpha
have been expressed in E. coli and purified to near homogeneity. These
receptors bind ligand with appropriate affinity and form homo- and
hetero-dimers on response elements which are permissive for dimerization.
Dimer formation is enhanced by ligand suggesting that ligand mediates
transcriptional activation by this mechanism. This application is a
comprehensive proposal to define the functional domains involved in
c-erbA, RAR, and related factors in transcriptional activation. For
these studies we constructed a multifunctional bacterial/eucaryotic
expression vector (pEXPRESS) which permits site directed mutagenesis and
can be used to functionally analyze receptor in eucaryotic cells and to
express receptor at high levels in E. coli. Gel shift studies using
purified wild-type and mutant receptor proteins and a variety of native
and synthetic response elements are proposed to elucidate the "rules"
which govern how these receptors recognize functional response elements.
These studies will also define receptor domains critical for homo- and
hetero-dimer formation, for cooperative interactions between receptors
and other factors, and for dominant negative activities. Possible
differences in element recognition by c-erbA subtypes (alphal and betal)
will also be examined along with studies to understand differences
between v-erbA and c-erbA and how c-erbA-alpha2 functions as a dominant
negative regulator. These studies will be complemented by analyzing
receptor mutants derived from patients with the thyroid hormone
resistance syndrome. Functional studies in mammalian cells will be
extended to in vitro transcription with the goal of defining the protein
and DNA requirements for transcriptional enhancement by these receptors.
Finally, the availability of mg amounts of purified E. coli expressed
wild-type c-erbA and its DNA binding domain will allow circular
dichroism, fluorescence, and ultraviolet-visible spectroscopy (both
proteins), and nuclear magnetic resonance studies (DNA binding domain) to
provide structural information to elucidate the functional and physical
properties of these proteins at the molecular level.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AMERSHAM BIOSCIENCES TYPHOON 9410; NEUROSCIENCES
-
批准号:7335290
-
项目类别:
-
资助金额:$1.93万
-
财政年份:2006
-
负责人:HERBERT H SAMUELS
-
依托单位:
AMERSHAM BIOSCIENCES TYPHOON 9410: PHARMACOLOGY, CELL BIOLOGY, MICROBIOLOGY
-
批准号:7335287
-
项目类别:
-
资助金额:$11.71万
-
财政年份:2006
-
负责人:HERBERT H SAMUELS
-
依托单位:
AMERSHAM BIOSCIENCES TYPHOON 9410: DRUG ABUSE
-
批准号:7335289
-
项目类别:
-
资助金额:$0.59万
-
财政年份:2006
-
负责人:HERBERT H SAMUELS
-
依托单位:
AMERSHAM BIOSCIENCES TYPHOON 9410: DIABETES
-
批准号:7335288
-
项目类别:
-
资助金额:$0.59万
-
财政年份:2006
-
负责人:HERBERT H SAMUELS
-
依托单位:
Amersham Biosciences Typhoon 9410
-
批准号:7047286
-
项目类别:
-
资助金额:$14.82万
-
财政年份:2006
-
负责人:HERBERT H SAMUELS
-
依托单位:
Training in Pharmacological Sciences
-
批准号:7088804
-
项目类别:
-
资助金额:$17.65万
-
财政年份:2004
-
负责人:HERBERT H SAMUELS
-
依托单位:
Training in Pharmacological Sciences
-
批准号:6914861
-
项目类别:
-
资助金额:$13.24万
-
财政年份:2004
-
负责人:HERBERT H SAMUELS
-
依托单位:
Training in Pharmacological Sciences
-
批准号:7695223
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2004
-
负责人:HERBERT H SAMUELS
-
依托单位:
Training in Pharmacological Sciences
-
批准号:8094304
-
项目类别:
-
资助金额:$17.68万
-
财政年份:2004
-
负责人:HERBERT H SAMUELS
-
依托单位:
Training in Pharmacological Sciences
-
批准号:7454116
-
项目类别:
-
资助金额:$9.38万
-
财政年份:2004
-
负责人:HERBERT H SAMUELS
-
依托单位:
Training in Pharmacological Sciences
-
批准号:7250038
-
项目类别:
-
资助金额:$17.65万
-
财政年份:2004
-
负责人:HERBERT H SAMUELS
-
依托单位:
Training in Pharmacological Sciences
-
批准号:6697544
-
项目类别:
-
资助金额:$8.83万
-
财政年份:2004
-
负责人:HERBERT H SAMUELS
-
依托单位:
Training in Pharmacological Sciences
-
批准号:7876978
-
项目类别:
-
资助金额:$17.49万
-
财政年份:2004
-
负责人:HERBERT H SAMUELS
-
依托单位:
GLUCOCORTICOID RECEPTORS--STRUCTURE AND FUNCTION
-
批准号:3241709
-
项目类别:
-
资助金额:$20.98万
-
财政年份:1989
-
负责人:HERBERT H SAMUELS
-
依托单位:
GLUCOCORTICOID RECEPTORS--STRUCTURE AND FUNCTION
-
批准号:3241708
-
项目类别:
-
资助金额:$20.66万
-
财政年份:1989
-
负责人:HERBERT H SAMUELS
-
依托单位:
GLUCOCORTICOID RECEPTORS--STRUCTURE AND FUNCTION
-
批准号:3241707
-
项目类别:
-
资助金额:$20.76万
-
财政年份:1989
-
负责人:HERBERT H SAMUELS
-
依托单位:
PHOTOAFFINITY LABELING OF THYROID HORMONE RECEPTORS
-
批准号:3152499
-
项目类别:
-
资助金额:$9.89万
-
财政年份:1983
-
负责人:HERBERT H SAMUELS
-
依托单位:
MULTIHORMONAL REGULATION OF GROWTH HORMONE SYNTHESIS
-
批准号:3151385
-
项目类别:
-
资助金额:$14.13万
-
财政年份:1978
-
负责人:HERBERT H SAMUELS
-
依托单位:
METABOLIC EFFECTS OF THYROID HORMONE
-
批准号:2137017
-
项目类别:
-
资助金额:$62.86万
-
财政年份:1976
-
负责人:HERBERT H SAMUELS
-
依托单位:
METABOLIC EFFECTS OF THYROID HORMONE
-
批准号:3483145
-
项目类别:
-
资助金额:$47.51万
-
财政年份:1976
-
负责人:HERBERT H SAMUELS
-
依托单位:
国内基金
海外基金
登录
查看更多内容
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
-
批准号:32302245
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:潘寒姁
-
依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
-
批准号:82371775
-
项目类别:面上项目
-
资助金额:46万元
-
批准年份:2023
-
负责人:朱慧媛
-
依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
-
批准号:31871817
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:孙爱东
-
依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
-
批准号:81873549
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2018
-
负责人:刘玉兰
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的分子机制
-
批准号:31571933
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2015
-
负责人:廖小军
-
依托单位:
超高压诱导牛肉中Escherichia coli O157:H7亚致死损伤及其修复研究
-
批准号:31371861
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:江芸
-
依托单位:
高压二氧化碳诱导Escherichia coli O157:H7形成VBNC状态的机制
-
批准号:31371845
-
项目类别:面上项目
-
资助金额:15.0万元
-
批准年份:2013
-
负责人:廖小军
-
依托单位:
高密度二氧化碳致死Escherichia coli的相关蛋白质确证及其结构变化研究
-
批准号:31171774
-
项目类别:面上项目
-
资助金额:66.0万元
-
批准年份:2011
-
负责人:张德权
-
依托单位: